- CH₣31.10bn
- CH₣34.30bn
- $11.16bn
Evotec agrees sale of France plant to Sandoz, shares rise
Brief: Sandoz Signs Non-Binding Term Sheet To Buy Just-Evotec Biologics In Toulouse
Brief: Evotec SE And Sandoz AG Planning Potential Sale Of Evotec Biologics Toulouse Site
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
Europe Inc's trade deal relief tempered by tariff reality (updated)
DB expects EU pharma 'malaise' to continue amid US headwinds
Southwest Airlines accuses drugmakers of price-fixing conspiracy in new lawsuit
Brief: Sandoz Announced Start Of Construction For Production Center For Sterile Product Manufacturing In Brnik, Slovenia
Brief: Sandoz Group Reports Q1 Sales Of $2.48 Bln, Confirms Guidance
Swiss stocks - Factors to watch on April 30
Brief: Sandoz Group Signs Global Collaboration Agreement With Henlius
Brief: Shanghai Henlius Biotech Enters License Agreement With Sandoz For Hlx13
Sandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient access
Swiss stocks - Factors to watch on April 22
Swiss stocks - Factors to watch on April 16
Swiss stocks - Factors to watch on April 15
Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug (updated)
Switzerland's Sandoz files antitrust lawsuit against Amgen in US
Brief: Sandoz Files Antitrust Litigation Against Amgen In The US